Tag Archives: media

The Doctor Game: Is home confinement a good time to fast? – The Westerly Sun

Today, nearly all of us are in enforced home confinement due to an invisible foe, the coronavirus. So, how do we amuse ourselves? Some pick up books theyve always wanted to read. Others get household chores done. But how about some of us losing weight? If typical busy schedules have interfered with your efforts in the past, could the current context support a concentrated effort on fasting to shed pounds? And what are the best ways to fast?

Fasting diets have generated considerable buzz among diet gurus in the media, not only as an approach to weight loss but also as a way to improve overall health. But do facts back it up?

Researchers say that animals and humans share some comment elements in the evolutionary process. One of these is that neither animals nor humans have always had the good fortune of enjoying three meals a day. Over long eras when our ancestors needed to scrounge for food, humans developed physiology capable of enduring periods without food. So the question arises, is it possible that the occasional fast might be good for us?

That seems to be true for animals. Studies show that fasting produces health benefits in laboratory animals. For instance, restrictive diet experiments involving rats and mice have delayed the progression of chronic conditions such as diabetes, cardiovascular diseases, cancer and neurological disorders.

Research suggests humans derive benefits too. For example, many studies look at the health impact of fasting by large numbers of people during Ramadan. Results show a reduction in inflammation biomarkers, and this in turn can help prevent a wide range of illness, including neurodegenerative conditions. Other benefits include reduced coronary artery disease and a lower risk of diabetes. Several studies have demonstrated that fasting can decrease blood sugar levels, improve blood sugar control, and reduce insulin resistance, facilitating efforts by those with diabetes to keep levels steady and prevent spikes and crashes.

If you decide to fast during home confinement, how should you do it? Some diets involve a complete fast, allowing only water for a period of time. But many people prefer intermittent fasting. This involves eating at only certain times of the day and fasting the rest of the day. Still other fasts involve drastically reducing food intake for two or three days of the week. Remember, fasting is about calorie restriction, and this is only advantageous if there is no overeating when breaking the fast.

Dr. Sai Krupa Das of the Human Nutrition Research Center on Aging says, In terms of weight loss and improvement on body composition, intermittent fasting can work, but there is not sufficient evidence to say it is superior to overall calorie restriction. In fact, the two methods appear to be pretty comparable.

A report in the journal Aging Research Reviews looked at various forms of calorie restriction. Researchers concluded that all forms of calorie restriction in overweight human subjects have shown improvement in multiple health indicators.

But Dr. Dariush Mozaffarian, dean of Tufts Friedman School of Nutrition Science and Policy, has sound advice. He says, Avoiding refined starches, grains, avoiding added sugars and other hyper-processed foods, and eating plenty of minimally processed foods such as nuts, seeds, beans, fruits, vegetables, fish, yogurt, healthy fats, and plant oils activates many natural weight controlling pathways.

The bottom line is to eat and diet in a way that works for you. Many complicated factors, including inherited genetics and socioeconomic context, make it difficult for some of us to maintain a healthy weight. But for too many of us, the problem is not genetic or societal. It is a lack of individual will and poor lifestyle choices that result in overconsumption of too many calories. This, combined with not enough exercise and confinement at home, is a recipe for trouble.

Dr. W. Gifford-Jones, aka Ken Walker, is a graduate of the University of Toronto and Harvard Medical School. You can reach him online at his website, docgiff.com, or via email at info@ docgiff.com.

See the article here:
The Doctor Game: Is home confinement a good time to fast? - The Westerly Sun

What About This? By Wayne William Cipriano – Douglas County Herald

I was wrong.

In a previous article presented here, I did not take Covid-19 as seriously as I should have. I should have taken into my consideration how resoundingly stipid so many persons have proven themselves to be.

Who would go out as before into an environment that offered a very high transmission rate of a fairly serious respiratory illness? Even before we learned how high the mortality rate was, the mere possibility of catching a very debilitating flu, you would think, would encourage all of us to stay away from places and situations where we could catch it.

In that previous article I argued that hysteria seemed to be ruling our news sources. I now realize that hysteria may well be a rational response in the face of a population that doesnt seem to understand simple precautions delivered in English and must, it seems, be scared into proper defensive behavior.

I suggested that the overall rate of illness and death would not be as damaging to us as a population as our yearly sacrifice of limb and life to automobiles. I suspect that I was wrong about that it looks like the final totals of casualties due to Covid-19 may surpass that over our use of the highways. But whether that proves to be the case or not, Covid-19 has really hurt us.

I listed the same few behaviors we have all heard so often to protect ourselves from Covid-19: wash our hands; avoid anyone coughing or sneezing; stay away from crowds; stay home if we are sick from ANYTHING. The things we seem to find so difficult to do.

In my defense, I thought many of us would follow those suggestions and I continue to believe if we had Covid-19 would not have been so bad here. But I should have recalled that if we over-react (hyper-hysteria) and we do not get sick, perhaps we look silly; if we under-react (by not following protective guidelines as so many, unaccountably, have not) we get sick, maybe dead.

We have hear of persons, cities, states that refused to recognize the danger of carrying on as normal when normal behavior could subject one to a very serious virus.

We have seen youngsters, totally lacking even the most self-protective impulses, almost dare Covid-19 to attack them. We have even seen parents and other responsible adults allow and even finance gatherings of these youngsters that place them in serious jeopardy.

But, that behavior is not simply of the young, is it?

I was wrong to rely on what I had considered rational persons would do in the face of a serious but fairly easily avoided epidemic. Some other guy might have waited to pontificate upon the hysteria that I called out in the media until the actual numbers were in. But if we always reserve our remarks until after the fact, wait until we see how each and every chip has fallen, we are not responsible social commentators, we are simply historians.

I will try to look at the future with a greater appreciation for what I have learned, once again, about human behavior. But I remain adamant that if ALL OF US washed our hands frequently, stayed away from anyone coughing or sneezing, avoided all crowds, and stayed home if we experienced any feelings of illness at all, Covid-19 would not have done to us what it has.

Has it come to pass that the only way to get people to do the right thing in cases such as this is to terrify them by what may happen even if those scary stories are irrational? But if we do we throw in the towel and admit that most of us are fools. Maybe there is a reason, maybe a very good reason to lie and exaggerate for the ultimate good. But what does that do to our (my) expectation to be told the Truth about other stuff?

I do not think that trade off is acceptable, even when it is employed in what some may think is the ultimate good. But thats just me. You have a say in this, too. What seems better to you?

Nevertheless, in that previous article in this space I was presumptively inaccurate.

I was wrong.

Related

Continue reading here:
What About This? By Wayne William Cipriano - Douglas County Herald

Vanda Pharmaceuticals Announces Initiation of “CALYPSO” to Study the Role of Genetic Variation in COVID-19 Infections in Collaboration With University…

WASHINGTON, April 15, 2020 /PRNewswire/ --Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the initiation of the CALYPSO program to study the role that human genetic variations play in SARS-CoV-2 ("COVID-19") infection and disease progression. As a part of the CALYPSO program, Vanda will collaborate with University of Washington School of Medicine and its Virology Lab on a pharmacogenetics study in patients with COVID-19. The study will focus on the sequencing of the genome of individual patients, as well as the COVID-19 virus, and the identification of genetic factors that correlate with disease progression and outcomes.

In support of this study, Vanda and UW Medicine plan to collect Whole-Genome Sequencing ("WGS") data from over 1,000 patients with COVID-19 infection, and perform Viral Genome Sequencing, which should enable Vanda and the UW Medicine Virology Lab to explore host susceptibility, associations of WGS with clinical outcomes and severity of disease, as well as host-virus interactions. The study is scheduled to begin enrollment in the coming weeks and will be open to patients in hospitals and clinics around the United States.

"We look forward to the advancement of our program and the opportunity to work with and leverage the expertise of UW Medicine to expand our understanding of the COVID-19 infection mechanism," said Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer of Vanda.

"The study has the potential to provide new insights into virushost interactions that could lead to more effective public health strategies and the design and development of vaccines and therapeutics," said Sandra P. Smieszek, Ph.D., Head of Genetics at Vanda. "With the vast amount of data we expect to collect, the team will aim to discern the factors associated with severity and other critical, clinical characteristics of the infected individuals."

"By leveraging our sequencing expertise and capabilities in collaboration with Vanda, we will be able to provide the necessary insight for potentially life-saving solutions for patients," said Alex Greninger M.D., Ph.D., M.S., M.Phil., Assistant Professor, Laboratory Medicine, Assistant Director, Virology Division at the University of Washington School of Medicine. "We believe this collaboration will help answer critical questions and hopefully outcomes in the fight against COVID-19."

"We are grateful to collaborate with Vanda as we try to find better ways to care for people currently suffering from COVID-19, and as we develop plans for the next phase of the national response," said Keith R. Jerome, M.D., Ph.D., Head of Virology Division at the University of Washington School of Medicine. "The approach of combining host and viral genomics to identify the most promising treatments may serve as a model for future efforts around the world. This unique agreement positions UW Medicine and Vanda for potentially changing the course of the COVID-19 pandemic."

"This is the type of collaboration we need to bring solutions to patients suffering in this time of crisis," said Dr. Greninger. "We look forward to getting this important work underway."

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com and follow us on Vanda's Twitter and LinkedIn.

About UW Virology

The UW Virology is one of nine divisions comprising the Department of Laboratory Medicine at the University of Washington School of Medicine. The UW Medicine Virology Clinical Laboratories perform diagnostic testing for a full range of human pathogens including respiratory viruses, herpes group viruses, HIV, hepatitis, and enteric viruses, and was one of the earliest providers of COVID-19 testing. The Division provides the highest quality patient care and serves as a model of excellence for clinical laboratories across the nation. Its UW Virology Lab is also recognized as a worldwide leader in virology research. UW Medicine Virology's research programs integrate the latest in computational, laboratory, and clinical research methods to advance the understanding of infectious diseases. Many past and current faculty members in the Virology Division have received prestigious awards recognizing their scientific achievements.

Vanda Contact:

AJ Jones IIChief Corporate Affairs and Communications OfficerVanda Pharmaceuticals Inc.202-734-3400

pr@vandapharma.com

UW Medicine Contact:

Susan GreggDirector, Media Relations 206-616-6730

sghanson@uw.edu

CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS

Various statements in this release are "forward-looking statements" under the securities laws. These forward-looking statements include, without limitation, statements regarding the design, enrollment and anticipated findings of the CALYPSO program, the promotion of more effective public health strategies and the design and development of vaccines and therapeutics. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Important factors that could cause actual results to differ materially from those reflected in Vanda's forward-looking statements include, among others: Vanda's ability to enroll patients for, and successfully conduct, the study described in this press release; the ability of Vanda, either alone or with its partners, to process the data collected and subsequently develop effective vaccines or therapeutics; the ability to obtain FDA approval of any such vaccines or therapeutics; and other factors that are set forth in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2019, which is on file with the SEC and available on the SEC's website at http://www.sec.gov. Additional factors may be set forth in those sections of Vanda's annual report on Form 10-Q for the fiscal quarter ended March 31, 2020, to be filed with the SEC in the second quarter of 2020. In addition to the risks described above and in Vanda's annual report on Form 10-K and quarterly reports on Form 10-Q, other unknown or unpredictable factors also could affect Vanda's results. There can be no assurance that the actual results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved. All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-initiation-of-calypso-to-study-the-role-of-genetic-variation-in-covid-19-infections-in-collaboration-with-university-of-washington-medicine-301041400.html

SOURCE Vanda Pharmaceuticals Inc.

See the rest here:
Vanda Pharmaceuticals Announces Initiation of "CALYPSO" to Study the Role of Genetic Variation in COVID-19 Infections in Collaboration With University...

Dont Like What the Virus Models Say? Try Building Your Own – Yahoo Finance

(Bloomberg Opinion) -- These are the best of times for disease modelers. They have the ear of presidents and prime ministers, and are getting huge amounts of news media attention. Their work is surely havinggreater impact now than ever before.

These are also the worst of times for disease modelers, because they have to model the behavior not just of diseases but also of the humans that carry them. This is always tough to get right, but far tougher when presidents, prime ministers and otherpeople are listening to the disease modelers and in some cases rapidly changing their behavior in response.

This conundrum has delivered some big forecast shifts. On March 16, the Covid-19 Response Team based at Imperial College Londons MRC Centre forGlobal Infectious Disease Analysiswas predicting thatin the (unlikely) absence of any control measures or spontaneous changes in individual behaviour, the disease would cause approximately 510,000 deaths in GB and 2.2 million in the US, not accounting for the potential negative effects of health systems being overwhelmed on mortality, a frightening forecastthat was said to have had a big impact at 10 Downing Street and the White House. Nine days later, the head of the team, Imperial College epidemiologist Neil Ferguson,was telling Parliament that U.K. deaths probablywouldnt top 20,000.

This was not the embarrassing admission of error it was made out to be by armchair epidemiologists on Twitter and in the media. Ferguson was simply saying that the worst-case scenario his team had modeled and dubbed unlikely had become even more unlikely as the government shifted policy and Britons began to take the disease more seriously, and that the best-case scenario in which social distancing efforts and case-based tracing and isolation halted the spread of the disease until a vaccine arrived had become more likely. Still, his updated mortality estimate was a little puzzling even for those of us who had read the initial report, and will almost certainly turn out to be too optimistic, given that the U.K. has alreadyreported more than 12,000 coronavirus deaths, with the daily death toll still rising, and thats probably a significant undercount given that it doesnt include most deaths from the disease outside of hospitals.

The model-based forecasts of coronavirus deaths and hospital-bed needs from the Institute for Health Metrics and Evaluation at the University of Washington havent produced quite that much whiplash, given that the first one on March 26 already assumed a significant amount of social distancing. But they too have produced rapidly changing estimates and a lot of head-scratching from observers by shifting within weeks from predicting that U.S. hospitals would soon be overwhelmed with Covid-19 patients to estimating now that peak resource usehas passed while, with some local exceptions, coming far short of exceeding hospital or intensive-care-unit capacity.

So one can kinda sorta see where Republican U.S. Senator John Cornyn was coming from when he tweeted last week:

The Wikipedia page that Cornynlinks to says the scientific methodinvolves formulatinghypotheses,making deductions based on them, testing those deductions against experimental or measurement-basedevidence, and then refining or eliminating the hypotheses. Far from being an indictment of the disease modelers, though, this describes more or less what theyve been doing: Formulating hypotheses about the behavior of the SARS-CoV-2 virus based on what theyve seen of it so far and what they know about other viruses, making deductions about the course of the disease based on those hypotheses and some hypotheses about human behavior, and then refining those hypotheses as new evidence comes in.

No, these arent thecontrolled experiments of laboratory science, but such modeling is probably the mostscientific way to tackle an emergent phenomenon like a pandemic or, for that matter, climate change although the disease modelers have the advantage of getting useful feedback on their forecasts much more quickly than the climate modelers usually do. The results of the Covid-19 models shouldnt be taken as the final word. Far from it. But they offer useful on-the-fly guidance that it would be ridiculous to ignore just because the eventual reality often turns out not to match the forecasts.

Story continues

To use these forecastsintelligently, I wonder if it might help if more politicians, journalists and others tried their hand atdisease modeling to get a sense of how it works. This is not hard to do these days, thanks to the excellentCovid-19 Scenarios site developed by scientists at the University of Basel in Switzerland and the Karolinska Institute in Sweden. Built around a simpleSusceptible-Infected-Recovered model of the sort that epidemiologists use, it allows users to tweak parameters ranging from Covid-19sreproduction rate (R0), a measure of how many people a person with the disease can be expected to infect,to its seasonality, its fatality rate and the expected length of hospital stays, then forecasts the diseases spread and impact based on demographic data from just about every country on earth. The site also allows one to impose interventions of varying duration and effectiveness and see what kind of impact they have, although at this point it doesnt say what exactly those interventions are (theyre working on that).

The horrifying (and by now seemingly quite unrealistic) intervention-free baseline of the model for the U.S. is that 95% of the population gets the disease and that a little over 1% of the infected, 3.3 million people, die. Thatfatality rate is not the unrealistic part, with estimates from epidemiologists so far seeming to convergearound 1%or a little lower. A much higher 6.2% of confirmed coronavirus cases worldwidehave died, but theres ample to reason to believe that confirmed cases represent a fraction of infections. There have been suggestions that they represent a quite tiny fraction, meaning that the disease is already widespread, the fatality rate is lower than the seasonal flus 0.1%and itll all be over soon. But local experiments with widespread or randomized testing for the disease have not backed up this view. A recentUniversity of Bonn study of the hard-hit German town of Gangelt, for example, found that 15% of residents were either infected with the new coronavirus or had antibodies indicating that they had been. This made for a fatality rate so far of 0.37%, whichis (1) several times worse than the seasonal flu, (2) possibly skewed by undercounted deaths and (3) likely to go up with the passage of time.

Thefatality rate could go downthanks to new treatments, or up if hospitals are overwhelmed. But 1% seems both reasonable and useful as a starting point, in part because it makes so clear that the key variable in most forecasts is how many people would be infected. Aforecast of 60,000 deaths in the U.S. from the coronavirus, the current working assumption at the White House, implies at a 1% fatality rate that only about 6 million people, or 1.8% of the population, will get the disease. (Given the greatly varying severity of the disease by age, it could also imply that more younger Americansget Covid-19 and that relatively few over 65 do, but Im trying to keep things simple here.) The 2.2 million-deathforecast in the Imperial College worst-case scenario, meanwhile, implies that about two-thirds of the U.S. population would get it, at or near the oft-cited threshold for herd immunity whereso many people have recovered from a disease and become at least temporarily immune to it that it can no longer spread. TheH1N1 pandemic of 2009-2010 stopped well short of that, though, with just under 20% of the U.S. population infected and the disease in decline even before a vaccine becamewidely available. That sounds encouraging, but if Covid-19 were to infect 20% of the U.S. population, the expected death toll (againassuming the age distribution of cases is the same as that of the population) would be 660,000.

My point in sharing all this morbid information is that if you want to criticize one of the model-based coronavirus forecasts as too pessimistic, or toooptimistic, you kind of need to have your own forecast of how many people will be infected and be willing to adjust it as new information comes in. Not so easy, right?

This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

Justin Fox is a Bloomberg Opinion columnist covering business. He was the editorial director of Harvard Business Review and wrote for Time, Fortune and American Banker. He is the author of The Myth of the Rational Market.

For more articles like this, please visit us at bloomberg.com/opinion

Subscribe now to stay ahead with the most trusted business news source.

2020 Bloomberg L.P.

Continued here:
Dont Like What the Virus Models Say? Try Building Your Own - Yahoo Finance

Leading with the Unknowns in COVID-19 Models – Scientific American

As the U.S. tops the chart on COVID-19 cases and growth rate, the theme of regret is ubiquitous in the media. Lost time that could have been spent enacting more stringent distancing measures weighs on the minds of many leaders and citizens. As a researcher in uncertainty visualization, I fear a different sort of regret from our response to COVID-19.

Many visualizations, including variations on the widely distributed Flatten the Curve graph represent estimates produced by models. These models simulate the number of people who would be infected, require hospitalization, or die under different conditions. Flatten the Curve adapts a visualization first presented by the CDC in 2007 to compare such estimates under different levels and durations of social distancing. The author added a dotted line to represent his estimate of the number of available hospital beds in the country.

It is easy to perceive the predictions of cases and deaths from simulations as complete depictions of what we can expect based on what we know. For one thing, these models take in multiple streams of available data: on COVID-19 cases, deaths, and rates of hospitalization; on how quickly COVID-19 spread under different conditions elsewhere in the world; and on how related viruses have spread in the past, to name a few.

Model results are powerful, because from them we can calculate risks. For example, How much more likely is it that our death rate reaches 10 percent of cases, as it has in Italy, under distancing measures? How likely is it that the virus will peak in two to three weeks? By quantifying unknowns, estimates of risks make clear that what will happen is not completely certain, but can nonetheless empower us to make decisions and weigh trade-offs.

What worries me as an expert in reasoning under uncertainty is a more difficult type of uncertainty: the uncertainty that arises from the many unknowns underlying COVID-19 data and models. We cant easily quantify this uncertainty, and it is easy to overlook, since it is not conveyed by model estimates alone.

One form of unquantifiable uncertainty stems from our limited ability to estimate how accurate the data that is input to these models is. Available data on COVID-19 case counts are likely to be unreliable as a result of large differences in the scale of testing in different locations, combined with inconsistencies in how testing is applied in a single location. This leads to case number comparisons of apples to oranges. A larger number of cases in one place, or even a higher rate of cases per capita, does not necessarily equate to a higher risk. More likely, it means health providers are testing more broadly in that location. Until we implement more comprehensive, nonselective testing, we cant quantify exactly how at risk of bias these data are.

Data on deaths from COVID-19 are likely to be more reliable, but may still be far from perfect. For example, it may be difficult to trace whether COVID-19 or another preexisting condition caused death in the elderly. Community decision-makers may also be incentivized to underreport deaths to avoid spreading panic or crippling a local economy.

A second form of unquantifiable uncertainty stems from the fact that models are often gross simplifications of real world situations. Many of the models being used to forecast our future under COVID-19 make strong assumptions that seem contradicted by what we expect in reality. Models vary in the assumptions they make about the mechanism behind disease transmission. Some approaches focus on fitting curves to available data rather than assuming mechanisms that account for realities like incubation periods and immunity after infection.

Others account for these dynamics, but make strong assumptions about the predictability of human behavior in the face of a crisis. Sometimes called ambiguity, non-numerical uncertainty like the unquantifiable inexactness of a model as a stand-in for reality means that our predictions could be off, by a little or by a lot depending on how flawed the model assumptions were. All models are wrong, but some are useful, said George Box, a statistician, reminding us of the tension between understanding models as tools for thinking versus expecting models to be oracles. Unfortunately, a careful critique of model assumptions, like other forthright presentations of uncertainty,, rarely makes it into the public-facing articles or visualizations used to present the results.

It is especially easy to overlook the strength of the assumptions models make because their predictions can seem comprehensive. Rather than producing a single number like a count, a model typically produces a set of predicted outcomes. Flatten the Curve, for example, shows two areas representing case counts over time: if we enact protective measures, and if we dont. A predicted number of infections is shown for each day after the first confirmed case.

Even when quantifiable uncertainty associated with the model predictions is not shownin this case, we do not see other values that the predicted case counts by day could take under the model assumptions--visualizations like Flatten the Curve can imply completeness through the series of predictions they produce. For many, seeing a graphical depiction of distributions of possibilities over time or space may seem like the epitome of scientific carefulness. Behind the seemingly precise visuals, however, are a number of approximations.

Does the presence of uncertainty make the extreme social distancing measures being enacted in many states an overreaction? Not necessarily. In the absence of good estimates of risk, it is rational to guard against worst case outcomes. Its the best we can do, until we get better data.

What is dangerous is if we fail to recognize the difference between model predictions made now based on limited information and strong assumptions, and more reliable data that will emerge over time as the virus plays out. If early model predictions turn out to overestimate COVID-19 deaths or the risk to our health system, or underestimate it by a significant amount, many may blame the scientists for being wrong. They may trust data-driven estimates less in the future.

Clear presentation of uncertainty can make model estimates seem less reassuring, but can prevent people from blaming the forecaster or the scientific enterprise itself, when, as we should expect, the model is wrong. Trading public trust in science in the future is not worth feeling more assured in the short term, no matter how much we seek to eliminate uncertainty.

Read the rest here:
Leading with the Unknowns in COVID-19 Models - Scientific American

Podcast: Nothing about me without meThe importance of involving patients in genomic research – Genetic Literacy Project

In this episode of Genetics Unzipped, recorded at the recent Festival of Genomics in London, Kat Arney finds out why its so important to make sure that both academic and commercial research studies are done with rather than on participants.

Research into genetic conditions relies on information from patients and their families, whether thats detailed health records or genomic data. As the tools and techniques for DNA and data analysis become cheaper and more organisations get in on this fast-growing field, its vital to make sure that the most valuable research resource human lives doesnt get overlooked in the rush.

Fiona Copelandis the chair of a support group for UK families affected by primary ciliary dyskinesia or PCD a rare genetic condition that affects the lungs and is the mother of two adult sons with the condition. Shes spent many years acting as a patient representative, engaging with academic and industry scientists looking to involve PCD patients in research into understanding and treating the condition. She explains what her role involves and shares her advice for how researchers can engage and involve patient groups more effectively. Her top tip? Dont make children cry!

Next Arney speaks with Patrick Short. Hes the CEO of Sano Genetics a Cambridge-based startup that aims to connect researchers with patients who want to take part in genomic research. While some companies using patients in research have come under scrutiny for poor handling of data and ethical compliance, Short is keen to help organizations do better and drive change in the fast-growing commercial genomics sector.

Finally, we hear from Shelley Simmonds, a disability rights campaigner and rare disease advocate whose son Fraser was initially given a diagnosis of Duchenne Muscular Dystrophy as a baby. When Fraser didnt seem to be progressing as might be expected for a child with the disease, she and her family got involved in Genomics Englands 100,000 Genomes Project in search of clarity but things turned out not to be quite so simple. Shelley talks what happens when the question Whats wrong with my child? has no answer.

Full transcript, links and references available online atGeneticsUnzipped.com

Genetics Unzippedis the podcast from the UKGenetics Society,presented by award-winning science communicator and biologistKat Arneyand produced byFirst Create the Media.Follow Kat on Twitter@Kat_Arney,Genetics Unzipped@geneticsunzip,and the Genetics Society at@GenSocUK

Listen to Genetics Unzipped onApple Podcasts(iTunes)Google Play,Spotify,orwherever you get your podcasts

See the article here:
Podcast: Nothing about me without meThe importance of involving patients in genomic research - Genetic Literacy Project

Equal roles for women in Indian Armed Forces: The road ahead – WION

The recent decisions of the Supreme Court regarding grant of permanent commission to women officersareseen as a landmark step towards women empowerment and corrective change to prevent perceived gender bias against women.

The concerns expressed by the government, on behalf of Indian Armed Forces, like physiology, motherhood and physical attributes, did not hold ground under the basic tenet of constitutional entitlement to dignity, which attaches to every individual irrespective of gender.

These are welcomed societal changes and the military system has to gear up accordingly to mitigate the concerns, yet ensuring that the operational effectiveness of the Armed Forces is not compromised. The issue was extensively covered by the media, and the Armed Forces responded positively with Army Chief indicating that the roadmap for granting permanent commission to women officers is being put in place. The implementation, however, needs some serious analysis of some key issues to.

Decoding Alleged Gender Bias in Indian Armed Forces

A glance at the open-source coverage of SC decisions, seemed to suggest that Indian Military had the patriarchal mindset and SC has bettered the system with this landmark judgement. The background needs to be put into perspective. The women were first inducted as Military Nursing Officers in 1927, as Medical Officers from 1943 in British Indian Army as per organisational needs to look after troops, families and public during deployments, which included female population. Post-independence, the Induction of women officers into the Indian Army through Women Special Entry Scheme (WSES) started in 1992, after the approval of the Cabinet Committee on Parliamentary Affairs.

In February 2019, the government granted a permanent commission to women officers in eight streams of the Army, in addition to the JAG and AEC, to which it was granted earlier in 2008. All these decisions were also pathbreaking, need-driven, societal changes taken voluntarily by Indian Military and not after the intervention of Courts; hence it may not be right to perceive that Indian Military carried patriarchal mindset and resisted such changes. It is a fact that there are different conditions of service for women officers and their men counterpart in most cases. These conditions of service keep getting modified to address concerns of women officers, starting from five years of service, changed to extendable by five years (5+5 years), followed by 5+5+4 and later made to 10+4 years.

The fact is that women officers are proud and essential members of the Indian military and their entry was need-based and not court driven.

The differences in conditions of service for women officers and their men counterparts can be perceived in favour, as well as, against them. No one can deny that women officers have concessions in physical standards during recruitment, in battle physical efficiency tests and are generally given softer appointments with due considerations to hygiene, sensitivities and privacy issues while accommodating them.

For selection they compete with female counterparts; hence selections of a specified number of women officers is assured, as they do not compete with men counterparts. The disadvantages of difference in service conditions were unequal growth opportunity to women officers, need for permanent commission and inadequate incentive, which have been the main reasons for the redressal given the Supreme Court. The cases wherein male officers tenures in difficult field stations have increased, in adjusting women officers for spouse postings, child care leave. This results in reduced leaves for male officers to be with family in peace locations, to attend to their family needs. Although male officers have not gone to courts against the resultant extra hardship caused in an attempt to help out women officers by the organisation.

This gender bias against men officers also needs to be set right. Gender Equality is the societal need of the hour and applies to both female and male officers and should be ensured in the spirit of the judgement.

Operational Efficiency and Command Assignments

To implement the latest rulings of the SC on the grant of permanent commission to all women officers, their terms of engagement will have to be revised. As per media report,s the Indian Military is already working out models for it and I am sure that the system will settle down in due course, with some adjustments. The selection for command assignments has to merit-based irrespective of gender, which must not be compromised to ensure operational efficiency of the Indian Armed Forces. Translating the same in the spirit of achieving gender equality and SC judgement, the same standards have to be applied across the board, without any gender bias.It entails same hardships be suffered by all officers and the same selection process followed for successive promotions, irrespective of the gender.

To implement the same, the selection for the command should be done through their confidential reports and closed promotion board, common for both genders, and the names and gender of the profile should be hidden from selection board.

The best officers should get the command irrespective of gender, as the troops respect competent leaders, who rough out inconvenient times with them. These are some basics of soldiering, which must not be violated to ensure operational efficiency. It means that the concessions given to women officers in recruitment and softer tenures must be withdrawn, and they must go through the field and rough appointments with troops, to be at par with male counterparts and be accepted as Leaders and not Appointed Officers.

Women Officersin Combat Arms

The fact that SC gave a decision, in March 2020, to induct women officers in all types of warships in Indian Navy, as a natural process of societal evolution, the possible induction of women into combat arms is going to be the next challenge, which Indian Military will be confronted with. The leadership in combat arms at each level, from detachment to highest formation, is laid on a bedrock principle of Leading from the front which must not be compromised.

It implies that all officers and soldiers must go through same selection, toughness schedule, promotion exams, command criteria assignments and appointments with no concessions. SC has also endorsed suitability of the candidate as one of the criteria for such assignments in its ruling on March 17, 2020. Most foreign armies having women officers already have gender neutrality in physical standards or are working towards it. The issues like physiology, minimal facilities for habitat, hygiene in combat ships, bunkers and long-range patrols, privacy needs, motherhood and childcare concerns are well known to women officers, as well as, courts and public.

The women officers who volunteer for combat arms must be determined to overcome these issues. The only aspect which needs to be ensured is that the standards should not be lowered to adjust women officers, otherwise it will amount to compromising operational effectiveness of military for appeasement of few.

The principle for selections in career progression should be the same as explained earlier for command assignments. It, therefore, implies that if every male infantry officer has to go through commando course, every women officer opting for infantry must go through the same. If every other combat arms officer has to go through Commando/Counterinsurgency/Mountain warfare course and serve in Rashtriya Rifle or Assam Rifle for at least one tenure, the same yardstick must apply to women officers.

(Disclaimer: The opinions expressed above are the personal views of the author and do not reflect the views of ZMCL)

Link:
Equal roles for women in Indian Armed Forces: The road ahead - WION

Genetic Testing: Are Over-the-Counter Options Reliable? – Curetoday.com

An expert raises her concerns about direct-to-consumer testing and shares ways people can protect themselves.

In an interview with CURE, Lisa Schlager, vice president of public policy for Facing Our Risk of Cancer Empowered (FORCE) and a BRCA1 mutation carrier, discussed OTC genetic tests versus those provided by health care professionals and what consumers should keep in mind as they make health decisions.

CURE: What are the major differences between OTC genetic tests and those ordered by a physician or genetic counselor?

Schlager: Its like night and day. As an example, 23andMe has a component where you can opt to test for the BRCA mutations, although it looks for only three of the potentially thousands of BRCA mutations. The BRCA1 and BRCA2 gene mutations are associated with increased risk of breast, ovarian, prostate and pancreatic cancer, and some people are interested to know if they may have one of these mutations.

But when youre testing for only three of the potentially 5,000 mutations, and those three mutations are most commonly found in the Ashkenazi Jewish population, youre going to miss a lot of information. The fact that the Ashkenazi Jewish population is about 2% of the population in the United States means that 98% of the population in this country is unlikely to have those specific mutations.

If you were to go to a genetic counselor or a health care specialist with expertise in genetics, they would talk to you about your family history, determine which testing is most appropriate and probably give you a test that is much more expansive.

We must understand also that BRCA mutations are not the only mutations that cause an increased risk of cancer. We now have dozens of mutations with names like PALB2, CHEK2, ATM and Lynch syndrome. These are all mutations that cause increased cancer risk, and if you test for only the three BRCA mutations, youre really not getting good information about your potential risk.

How can consumers determine which OTC tests are reputable?

There have been a lot of reports in the media of people selling tests to unwitting consumers who dont realize who they are dealing with, who dont realize that theyre being duped out of their insurance or Medicare information. I think the important thing is that if you go to a qualified health care professional, they are more likely to steer you to a reputable genetic test. If youre going to do a test over the counter, look at it for what it is. Its kind of a fun thing, and it may provide you with some interesting information, but the best place to learn about health risks and health conditions is through a qualified health care professional or genetics counselor. Ultimately, if you do test positive for one of these health risks ... you need to confirm it with a health care provider anyway. The other thing to be aware of is that if something seems suspicious, go with your gut.

Should consumers be more aware of certain characteristics of these fraudulent tests?

Absolutely. (Be wary of) those that are making promises about coverage and that everyone is able to get it covered now, 100% free or no cost to you, or if they are aggressively marketing. We have seen people marketing these tests at health fairs and senior centers. Thats not a reputable way to do this. Thats not how health care is supposed to be done.

Some of these tests, such as 23andMe, have been approved by the Food and Drug Administration (FDA). What does this mean?

FDA approval means that the FDA has vetted it and determined that the test is in fact accurate for what it claims to do. The reality is that the vast majority of genetic tests are not FDA approved, they are CLIA (Clinical Laboratory Improvement Amendments) approved, which is a designation under the Centers for Medicare & Medicaid Services.

So, it comes down to knowing who is providing the test to you and making sure that the company, the test provider, the laboratory, is a reputable lab.

What is the biggest takeaway for consumers who are concerned about their risk?

Talk to a doctor that you have a relationship with and share your concerns. Most doctors will either have a mechanism for assessing risk in office or will refer you.

Ultimately, there is coverage for genetic testing for people who have a family history or personal cancer history. People dont need to turn to these less reliable tests to get the testing.

Originally posted here:
Genetic Testing: Are Over-the-Counter Options Reliable? - Curetoday.com

You Cant Spell Creative Without A.I. – The New York Times

This article is part of our latest Artificial Intelligence special report, which focuses on how the technology continues to evolve and affect our lives.

Steve Jobs once described personal computing as a bicycle for the mind.

His idea that computers can be used as intelligence amplifiers that offer an important boost for human creativity is now being given an immediate test in the face of the coronavirus.

In March, a group of artificial intelligence research groups and the National Library of Medicine announced that they had organized the worlds scientific research papers about the virus so the documents, more than 44,000 articles, could be explored in new ways using a machine-learning program designed to help scientists see patterns and find relationships to aid research.

This is a chance for artificial intelligence, said Oren Etzioni, the chief executive of the Allen Institute for Artificial Intelligence, a nonprofit research laboratory that was founded in 2014 by Paul Allen, the Microsoft co-founder.

There has long been a dream of using A.I. to help with scientific discovery, and now the question is, can we do that?

The new advances in software applications that process human language lie at the heart of a long-running debate over whether computer technologies such as artificial intelligence will enhance or even begin to substitute for human creativity.

The programs are in effect artificial intelligence Swiss Army knives that can be repurposed for a host of different practical applications, ranging from writing articles, books and poetry to composing music, language translation and scientific discovery.

In addition to raising questions about whether machines will be able to think creatively, the software has touched off a wave of experimentation and has also raised questions about new challenges to intellectual property laws and concerns about whether they might be misused for spam, disinformation and fraud.

The Allen Institute program, Semantic Scholar, began in 2015. It is an early example of this new class of software that uses machine-learning techniques to extract meaning from and identify connections between scientific papers, helping researchers more quickly gain in-depth understanding.

Since then, there has been a rapid set of advances based on new language process techniques leading a variety of technology firms and research groups to introduce competing programs known as language models, each more powerful than the next.

What has been in effect an A.I. arms race reached a high point in February, when Microsoft introduced Turing-NLG (natural language generation), named after the British mathematician and computing pioneer Alan Turing. The machine-learning behemoth consists of 17 billion parameters, or weights, which are numbers that are arrived at after the program was trained on an immense library of human-written texts, effectively more than all the written material available on the internet.

As a result, significant claims have been made for the capability of language models, including the ability to write plausible-sounding sentences and paragraphs, as well as draw and paint and hold a believable conversation with a human.

Where weve seen the most interesting applications has really been in the creative space, said Ashley Pilipiszyn, a technical director at OpenAI, an independent research group based in San Francisco that was founded as a nonprofit research organization to develop socially beneficial artificial intelligence-based technology and later established a for-profit corporation.

Early last year, the group announced a language model called GPT-2 (generative pretrained transformer), but initially did not release it publicly, saying it was concerned about potential misuse in creating disinformation. But near the end of the year, the program was made widely available.

Everyone has innate creative capabilities, she said, and this is a tool that helps push those boundaries even further.

Hector Postigo, an associate professor at the Klein College of Media and Communication at Temple University, began experimenting with GPT-2 shortly after it was released. His first idea was to train the program to automatically write a simple policy statement about ethics policies for A.I. systems.

After fine-tuning GPT-2 with a large collection of human-written articles, position papers, and laws collected in 2019 on A.I., big data and algorithms, he seeded the program with a single sentence: Algorithmic decision-making can pose dangers to human rights.

The program created a short essay that began, Decision systems that assume predictability about human behavior can be prone to error. These are the errors of a data-driven society. It concluded, Recognizing these issues will ensure that we are able to use the tools that humanity has entrusted to us to address the most pressing rights and security challenges of our time.

Mr. Postigo said the new generation of tools would transform the way people create as authors.

We already use autocomplete all the time, he said. The cat is already out of the bag.

Since his first experiment, he has trained GPT-2 to compose classical music and write poetry and rap lyrics.

That poses the question of whether the programs are genuinely creative. And if they are able to create works of art that are indistinguishable from human works, will they devalue those created by humans?

A.I. researchers who have worked in the field for decades said that it was important to realize that the programs were simply assistive and that they were not creating artistic works or making other intellectual achievements independently.

The early signs are that the new tools will be quickly embraced. The Semantic Scholar coronavirus webpage was viewed more than 100,000 times in the first three days it was available, Dr. Etzioni said. Researchers at Google Health, Johns Hopkins University, the Mayo Clinic, the University of Notre Dame, Hewlett Packard Labs and IBM Research are using the service, among others.

Jerry Kaplan, an artificial-intelligence researcher who was involved with two of Silicon Valleys first A.I. companies, Symantec and Teknowledge during the 1980s, pointed out that the new language modeling software was actually just a new type of database retrieval technology, rather than an advance toward any kind of thinking machine.

Creativity is still entirely on the human side, he said. All this particular tool is doing is making it possible to get insights that would otherwise take years of study.

Although that may be true, philosophers have begun to wonder whether these new tools will permanently change human creativity.

Brian Smith, a philosopher and a professor of artificial intelligence at the University of Toronto, noted that although students are still taught how to do long division by hand, calculators now are universally used for the task.

We once used rooms full of human computers to do these tasks manually, he said, noting that nobody would want to return to that era.

In the future, however, it is possible that these new tools will begin to take over much of what we consider creative tasks such as writing, composing and other artistic ventures.

What we have to decide is, what is at the heart of our humanity that is worth preserving, he said.

Original post:
You Cant Spell Creative Without A.I. - The New York Times

Spelling the Dream: How an Austin kid is part of an American dynasty – KXAN.com

AUSTIN (KXAN) Its you against the dictionary.

Thats how producer Chris Weller describes the national spelling bee scene, and in his upcoming Netflix documentary Spelling the Dream, he features an Austin native and if a dictionary could be afraid of someone, it would be terrified of him.

Weller describes Austins Nihar Janga, now a freshman in high school, as someone who dominates with humility. Janga shared the 2016 Scripps National Spelling Bee title with Jairam Hathwar as a fifth-grader, and is part of one of the most impressive dynasties in American competition Indian-American students winning the nations top spelling competition.

The past 12 champs have been Indian-American, and since 1999, 19 of the past 23 winners have ethnic roots from the Asian nation. Weller, a spelling bee fan himself, noticed the trend in 2013 and wondered why it was happening.

He met Sam Rega (who previously made the documentary Breaking the Bee), a co-writer and director of the documentary, in 2015. He pitched the idea of exploring the trend to Rega, and off they went.

You could say curiosity drew me in, Weller said, but the families and the kids are what kept me committed.

Weller and Rega followed four spelling bee champions for the film. One of them was Janga. What struck Weller most about Janga was how gracious and respectful he was to his competitors.

He knows his stuff, but he isnt boastful, Weller said. He celebrated equally if he spelled his word correctly and if his opponent, Jairam Hathwar, got his word right.

Janga said he started doing spelling bees in kindergarten because he enjoyed putting letters together to make words, and he won his first national championship in the third grade. He won both the spelling and vocabulary bees at the North South Foundation National Finals, and after he missed the Scripps National Spelling Bee by one spot the year after, in 2015, he said he dedicated himself to making the field.

I started my intensive training daily after that, Janga said. My mom coached me by preparing word lists and quizzing me on not only the correct order of the letters, but also their etymology and definitions to ensure my understanding of the words usage in the real world, rather than just its spelling.

Jangas training paid off, and he said his success doesnt just reflect his hard work. He said the prize also belongs to his family, and they helped him every step of the way.

I really enjoyed preparing for the bees because it was a family effort and brought us together every day, he said. He also mentioned that after competitions were done, he and his family planned to take a long trip to get away from it all.

And when hes not in a spelling competition, he goes out and wins geography bees, too. Hes the first person in history to win both the Scripps National Spelling Bee and the National Geographic Geography Bee. He picked up the geography bee championship last year, and said hed dream about winning both competitions.

And typically, after he realized those dreams, it was the best feeling hed ever felt.

Both times, it felt like I was dancing on the clouds above the summit of Mount Everest, he said.

Weller said he wanted to make this documentary to celebrate the success of kids like Janga. He was well-aware of all the stereotypes that go along with the spelling bee and the kids in them, and he wanted to make sure the film put success at the forefront.

Race and culture are always sensitive topics in filmmaking, even more so if the story involves kids, he said. So from the very beginning we promised ourselves that this would be a celebratory film. It would honor the culture and tell the story from the points of view of the people living the story.

Weller made sure to mention that these kids are just like any other American kid, that they spend their free time doing more than just reading a dictionary and studying. Some are musicians, some love to play video games and some are into other sports. Janga himself said he took up rowing in the past year, and now hes active in the Austin Rowing Club and loves it.

Im trying my best to become really good at it, Janga said.

Weller said the films focus is on the kids, whom he calls the stars of the show, but he and his team also realize that the stereotypes are out there and addressed them.

We included commentary from social scientists on issues like social media bullying and representation in the media, Weller said.

Also included in the film are perspectives from nationally-recognized Indian-Americans in television, comedy and sports. CNNs Dr. Sanjay Gupta and Fareed Zakaria, comedian Hari Kondabolu, ESPNs Kevin Negandhi and 1999 Scripps Spelling Bee champion Nupur Lala help give context to what the winning streak means to the community theyre all part of.

Janga has aspirations of becoming a neurosurgeon, and specifically, he wants to research Alzheimers disease and brain tumors to figure out how to reverse their effects.

I want to take on the social responsibility to fight against mental health issues, primarily in teenagers, as that is a huge problem that needs to be mitigated, he said.

He plans to be involved in anthropology and sociology organizations so he can better understand human behavior and the impact of surrounding society.

Janga has lofty goals, theres no doubt about that. If anybody can accomplish goals like that, Weller says its Janga.

His passion for academics and committing himself to mastering on competition after another both inspire me, and fills me with incredible guilt for all those years I spent playing video games. Weller said.

The film hits Netflix on May 23, the day before the 2020 Scripps National Spelling Bee was supposed to begin. The COVID-19 pandemic has led organizers to suspend it this year. You can read more about Netflixs upcoming releases on its website.

Read the original:
Spelling the Dream: How an Austin kid is part of an American dynasty - KXAN.com